Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sidharth Mehan

Showing results (91-100 of 127) with videos related to

Pageof 13
Sort By:
Human & Experimental Toxicology|April 4, 2022
Protective effects of apigenin on methylmercury-induced behavioral/neurochemical abnormalities and neurotoxicity in ratsRajeshwar Kumar Yadav, Sidharth Mehan, Rakesh Sahu, et al.
Saudi Journal of Biological Sciences|November 12, 2021
Neuroprotective efficacy of 4-Hydroxyisoleucine in experimentally induced intracerebral hemorrhageEhraz Mehmood Siddiqui, Sidharth Mehan, Shubham Upadhayay, et al.
Genes|July 27, 2022
Nrf2/HO-1 Signaling Stimulation through Acetyl-11-Keto-Beta-Boswellic Acid (AKBA) Provides Neuroprotection in Ethidium Bromide-Induced Experimental Model of Multiple SclerosisShubham Upadhayay, Sidharth Mehan, Aradhana Prajapati, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|January 15, 2025
The Polygenic Nature of Multiple Sclerosis: Genetic Variants, Immunological Modulation, and Environmental ConnectionsZuber Khan, Sidharth Mehan, Pankaj Kumar Maurya, et al.
Current Neurovascular Research|May 15, 2026
Advancing the Frontiers of Multiple Sclerosis Management: Emerging Immunotherapeutic StrategiesInjamamul Haque, Koushik Das, Zuber Khan, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|April 10, 2025
Integrating Gut-Brain Axis: Exploring the Neurogastrointestinal Interactions and Therapeutic Potentials in Autism Spectrum DisorderManjeet Kumar, Sidharth Mehan, Tarun Sharma, et al.
Molecules (Basel, Switzerland)|June 24, 2022
Activation of IGF-1/GLP-1 Signalling via 4-Hydroxyisoleucine Prevents Motor Neuron Impairments in Experimental ALS-Rats Exposed to Methylmercury-Induced NeurotoxicityAmbika Shandilya, Sidharth Mehan, Sumit Kumar, et al.
Current Molecular Medicine|September 27, 2024
Exploring the Neuroprotective Potential of Icariin through Modulation of Neural Pathways in the Treatment of Neurological DiseasesSarthak Sharma, Sidharth Mehan, Zuber Khan, et al.
Toxicology Reports|July 5, 2022
Effect of alpha-mangostin in the prevention of behavioural and neurochemical defects in methylmercury-induced neurotoxicity in experimental ratsRakesh Sahu, Sidharth Mehan, Sumit Kumar, et al.
European Journal of Pharmacology|February 26, 2025
Navigating the complexities of neuronal signaling and targets in neurological disorders: From pathology to therapeuticsDivya Choudhary, M D Nasiruddin Khan, Zuber Khan, et al.
Pageof 13

Showing results (91-100 of 127) with videos related to

Sort By:
Pageof 13
Human & Experimental Toxicology|April 4, 2022
Protective effects of apigenin on methylmercury-induced behavioral/neurochemical abnormalities and neurotoxicity in ratsRajeshwar Kumar Yadav, Sidharth Mehan, Rakesh Sahu, et al.
Saudi Journal of Biological Sciences|November 12, 2021
Neuroprotective efficacy of 4-Hydroxyisoleucine in experimentally induced intracerebral hemorrhageEhraz Mehmood Siddiqui, Sidharth Mehan, Shubham Upadhayay, et al.
Genes|July 27, 2022
Nrf2/HO-1 Signaling Stimulation through Acetyl-11-Keto-Beta-Boswellic Acid (AKBA) Provides Neuroprotection in Ethidium Bromide-Induced Experimental Model of Multiple SclerosisShubham Upadhayay, Sidharth Mehan, Aradhana Prajapati, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|January 15, 2025
The Polygenic Nature of Multiple Sclerosis: Genetic Variants, Immunological Modulation, and Environmental ConnectionsZuber Khan, Sidharth Mehan, Pankaj Kumar Maurya, et al.
Current Neurovascular Research|May 15, 2026
Advancing the Frontiers of Multiple Sclerosis Management: Emerging Immunotherapeutic StrategiesInjamamul Haque, Koushik Das, Zuber Khan, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|April 10, 2025
Integrating Gut-Brain Axis: Exploring the Neurogastrointestinal Interactions and Therapeutic Potentials in Autism Spectrum DisorderManjeet Kumar, Sidharth Mehan, Tarun Sharma, et al.
Molecules (Basel, Switzerland)|June 24, 2022
Activation of IGF-1/GLP-1 Signalling via 4-Hydroxyisoleucine Prevents Motor Neuron Impairments in Experimental ALS-Rats Exposed to Methylmercury-Induced NeurotoxicityAmbika Shandilya, Sidharth Mehan, Sumit Kumar, et al.
Current Molecular Medicine|September 27, 2024
Exploring the Neuroprotective Potential of Icariin through Modulation of Neural Pathways in the Treatment of Neurological DiseasesSarthak Sharma, Sidharth Mehan, Zuber Khan, et al.
Toxicology Reports|July 5, 2022
Effect of alpha-mangostin in the prevention of behavioural and neurochemical defects in methylmercury-induced neurotoxicity in experimental ratsRakesh Sahu, Sidharth Mehan, Sumit Kumar, et al.
European Journal of Pharmacology|February 26, 2025
Navigating the complexities of neuronal signaling and targets in neurological disorders: From pathology to therapeuticsDivya Choudhary, M D Nasiruddin Khan, Zuber Khan, et al.
Pageof 13